Status:
COMPLETED
Quantification of the Time and Effort Required for Peripheral Blood Stem Cell Collection -The European Perspective
Lead Sponsor:
Pr Mohamad MOHTY
Conditions:
Lymphoma
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to observe the effects of the availability of plerixafor on the time and effort associated with autologous peripheral blood stem cell collection.
Detailed Description
This non interventional study will consist of two parts: I. Retrospective study: A medical record review will be conducted covering 200 patients file undergoing peripheral blood stem cell mobilizati...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients must satisfy the following for the part 1
- Oncology patients diagnosed with Non-Hodgkin lymphoma who are candidates for autologous hematopoietic stem cell transplantation (HSCT)
- A patient that fails to achieve a target CD34+\>20 cells/µl, before or on the first day of apheresis
- Age \> 18 years
- Exclusion Criteria for the part 1
- Patients with:
- Age \< 18 years;
- Primary diagnosis other than Non-Hodgkin lymphoma
- Undergone prior autologous hematopoietic stem cell transplantation (HSCT)
Exclusion
Key Trial Info
Start Date :
October 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
248 Patients enrolled
Trial Details
Trial ID
NCT02287012
Start Date
October 1 2013
End Date
October 1 2015
Last Update
October 7 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.